Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

GOLD guidelines recommend using these for patients with recurrent exacerbations or moderate COPD adjunct therapy to a long-acting bronchodilator. Yet, more than one fourth of surveyed physicians ...

New long-acting technologies are changing the HIV prevention landscape. In recent years, innovation in pre-exposure prophylaxis (PrEP) has accelerated. Long acting injectable cabotegravir and the ...

They included U.S. patients with COPD from April 2017 to August 2024 who initiated dupilumab or long-acting β2-agonist (LABA) therapies. Patients with asthma or lung cancer were excluded. They ...

GENEVA, 8 October 2024—Responding to ViiV’s announcement on long-acting cabotegravir , UNAIDS Executive Director Winnie Byanyima said: “New HIV prevention medication, in the form of a long-acting ...

The company has revealed its commitment to make at least two million doses of long-acting cabotegravir for HIV pre-exposure prophylaxis (CAB LA for PrEP) available for procurement for low- and ...

The right treatment plan can help you control your COPD symptoms and avoid exacerbations (flareups). These include shortness ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Thousands of people with HIV will now be offered a new long-acting injection to manage their condition if they would prefer to stop taking daily pills. Charities have welcomed the approval of the ...

Indacaterol (brand name, Arcapta) is a long-acting bronchodilator from the beta agonists (LABA) class. It is used for breathing difficulties such as wheezing, shortness of breath, coughing, and chest ...